Table 1.

Demographic and medical characteristics for the total sample and by ostomy group

Variable	Total (N=141; N (%))	Never had ostomy (n =98; N (%))	Past ostomy (n =18; N (%))	Current ostomy (n =25; N (%))
Age (mean±SD, year)	57.7±13.2	58.4±13.5	61.3±9.3	52.2±13.0
Female gender	59 (41.8)	40 (40.8)	7 (38.9)	12 (48.0)
Education
Less than a bachelor’s degree	46 (32.6)	31 (31.6)	8 (44.4)	7 (28.0)
Bachelor’s degree or advanced degree	95 (67.4)	67 (68.4)	10 (55.6)	18 (72.0)
Ethnicity
Caucasian	117 (83.0)	81 (82.6)	16 (88.9)	20 (80.0)
African American	11 (7.8)	8 (8.2)	1 (5.6)	2 (8.0)
Asian	9 (6.4)	5 (5.1)	1 (5.6)	3 (12.0)
Other	4 (2.8)	4 (4.1)	0 (0.0)	0 (0.0)
Marital status
Married or cohabiting	121 (85.8)	83 (84.7)	17 (94.4)	21 (84.0)
Tumor site
Colon	104 (73.8)	85 (86.7)	7 (38.9)	12 (48.0)
Rectum	37 (26.2)	13 (13.3)	11 (61.1)	13 (52.0)
Disease stage at survey
I	13 (9.2)	10 (10.2)	2 (11.1)	1 (4.0)
II/IIA	24 (17.0)	19 (19.4)	1 (5.6)	4 (16.0)
IIIA	3 (2.1)	2 (2.0)	1 (5.6)	0 (0.0)
IIIB	22 (15.6)	12 (12.2)	5 (27.8)	5 (20.0)
IIIC	9 (6.4)	6 (6.1)	1 (5.6)	2 (8.0)
IV	70 (49.6)	49 (50.0)	8 (44.4)	13 (52.0)
Currently receiving treatment	56 (39.7)	40 (40.8)	4 (22.2)	12 (48.0)
Length of time since diagnosis (months)	31.5±23.0	31.7±24.6	36.3±15.1	27.1±20.8
Treatment received
Surgery	132 (93.6)	89 (90.8)	18 (100.0)	25 (100.0)
Chemotherapy	106 (75.2)	68 (69.4)	16 (88.9)	22 (88.0)
Radiation	45 (31.9)	16 (16.3)	14 (77.8)	15 (60.0)
Colostomy (vs. ileostomy)	13 (9.2)	–	2 (11.1)	11 (44.0)
Pelvic surgery	50 (35.5)	17 (17.3)	15 (83.3)	18 (72.0)
Perforations during surgery	6 (4.3)	3 (3.1)	1 (5.6)	2 (8.0)
Obstruction during surgery	18 (12.8)	11 (11.2)	3 (16.7)	4 (16.0)
Post-operative complications	32 (22.7)	16 (16.3)	6 (33.3)	10 (40.0)
Received Folfox	77 (54.6)	51 (52.0)	9 (50.0)	17 (68.0)
Received Folfiri	22 (15.6)	17 (17.3)	2 (11.1)	3 (12.0)
Received Xelox/Xeloda	20 (14.2)	12 (12.2)	5 (27.8)	3 (12.0)